# Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment

> **NCT02587819** · PHASE1 · COMPLETED · sponsor: **Biosceptre** · enrollment: 21 (actual)

## Conditions studied

- Carcinoma, Basal Cell (BCC)

## Interventions

- **DRUG:** Treatment with BSCT

## Key facts

- **NCT ID:** NCT02587819
- **Lead sponsor:** Biosceptre
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-10
- **Final completion:** 2014-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587819, "Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02587819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*